Similar collective action problems arise during cancer development, where growth factors support tumor growth by protecting cells from apoptosis (for example, IGF-II), by stimulating the growth of new blood vessels (for example, VEGF), by impairing immune system reaction (for example, TGFβ), or by promoting the epithelial–mesenchimal transition. The gene discussed is IGF2; the disease is cancer.